[Metabolic syndrome]

Nihon Rinsho. 2009 Apr;67(4):771-6.
[Article in Japanese]

Abstract

Angiotensin II suppresses the insulin sensitivity via enhancement of serine phosphorylation of insulin receptor and suppression of tyrosine phosphorylation of IRS-1. Adiponectin increases insulin sensitivity, and TNF-alpha decreases insulin sensitivity. From our studies, the suppressed adiponectin and increased TNF-alpha may play an important role of the insulin resistance mechanisms. Angiotensin II suppresses the differentiation of adipocyte. Large sized adipocytes increase TNF-alpha and decrease adiponectin. Angiotensin II also has the direct stimulating action on TNF-alpha synthesis. ARB increases adiponectin a nddecreases TNF-alpha. Improvements of these adipocytokines dysfunction by ARB may concern tothe improvement of insulin resistance. The significance of various adipocytokines in insulin resistance and metabolic syndrome is also introduced.

Publication types

  • Review

MeSH terms

  • Angiotensin Receptor Antagonists*
  • Humans
  • Insulin Resistance / physiology
  • Metabolic Syndrome / drug therapy*
  • Metabolic Syndrome / physiopathology
  • Renin-Angiotensin System / physiology

Substances

  • Angiotensin Receptor Antagonists